SEC Tracker
Get the app

4D Molecular Therapeutics FDMT

4D Molecular Therapeutics, Inc. announced its intention

Form
8-K
Filed
Importance
Routine
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when 4D Molecular Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. XOMA Royalty XOMA public float $168M, Jun 30, 2025
  2. Lexicon Pharmaceuticals LXRX public float $170M, Jun 30, 2025
  3. Lineage Cell Therapeutics LCTX public float $162M, Jun 30, 2025
  4. Omeros OMER public float $172M, Jun 30, 2025
  5. Forte Biosciences FBRX public float $157M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.